Cardiovascular Systems Inc 4

4 · Cardiovascular Systems Inc · Filed Feb 27, 2015

Form 4

Period: 2015-02-25

DirectorPresident and CEO

Transactions

Exercise/Conversion
Stock Option (right to buy)
2015-02-25−20,800→ 0 total
Exercise: $8.83Exp: 2017-02-14→ Common Stock (20,800 underlying)
Exercise/Conversion
Common Stock
2015-02-25$8.83/sh+20,800$183,664→ 392,489 total
Sale
Common Stock
2015-02-25$37.00/sh−20,800$769,600→ 371,689 total
Sale
Common Stock
2015-02-25$37.24/sh−2,000$74,479→ 369,689 total
Gift
Common Stock
2015-02-27−2,271→ 367,418 total

Holdings

Common Stock
(indirect: By Children)
850
Stock Option (right to buy)
Exercise: $7.90Exp: 2017-06-11→ Common Stock (90,580 underlying)
90,580
Stock Option (right to buy)
Exercise: $12.15Exp: 2017-12-11→ Common Stock (234,395 underlying)
234,395
Stock Option (right to buy)
Exercise: $8.75Exp: 2019-03-01→ Common Stock (32,350 underlying)
32,350
Common Stock
(indirect: By Children)
850
Common Stock
(indirect: By Children)
350

Footnotes (4)

[F1]The shares were sold pursuant to a Rule 10b5-1 trading plan.
[F2]Sale of shares to provide funds to satisfy certain tax obligations of the reporting person.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.155 to $37.3243 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]Fully exercisable.

Documents

1 file